Oxervate
Oxervate is a medicine authorised by Swissmedic under authorisation number 67019. The authorisation holder is Dompé International SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 September 2018 and the authorisation is valid without a time limit. ATC code S01XA24 places the medicine in the group Ophthalmologicals.
| Authorisation number | 67019 |
|---|---|
| Name | Oxervate |
| Full name | Oxervate, collyre |
| Authorisation holder | Dompé International SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | S01XA24 |
| First authorisation | 06 September 2018 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Oxervate, collyre | B | 06 September 2018 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 7 | Durchstechflasche(n) | S01XA24 | 11.99.0. | B |
Scroll the table sideways
Frequently asked questions
Is Oxervate authorised in Switzerland?
Yes. Oxervate is authorised by Swissmedic under authorisation number 67019, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Oxervate have?
Oxervate is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Oxervate?
The authorisation holder is Dompé International SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.